基于计算机断层扫描、磁共振成像及超声内镜的胰腺神经内分泌肿瘤术前分级预测
该回顾性研究纳入58例病理确诊的胰腺神经内分泌肿瘤患者,分为1级与2/3级,利用术前一周内的CT、MRI及超声内镜图像建立预测模型。性别、胰管扩张及门脉期强化比率为独立预测因子(P<0.05),三者联合的AUC为0.925;超声内镜弹性成像评分的AUC为0.838。作者提出基于术前多模态影像的综合模型有助于预测肿瘤分级并辅助个体化诊疗。
要点
- 性别、胰管扩张及门脉期强化比率是胰腺神经内分泌肿瘤分级的独立预测因子。
- 三者联合模型预测1级与2/3级的AUC达0.925,优于任一单独预测因子。
- 超声内镜弹性成像评分对分级的AUC为0.838。
核心结论
- 基于术前CT、MRI及超声内镜的综合模型可预测胰腺神经内分泌肿瘤1级与2/3级,并更好地为临床个体化诊疗提供信息。
研究设计与样本
- 回顾性研究,纳入58例病理确诊的胰腺神经内分泌肿瘤患者,分为1级与2/3级,采集术前一周内的CT、MRI及超声内镜图像,建立基于独立临床危险因素与显著影像学特征的临床预测模型,以受试者工作特征曲线下面积(AUC)评估模型。
诊断标准与关键数值
- 性别、胰管扩张及门脉期强化比率为分级的独立预测因子(P<0.05);三者联合预测1级与2/3级的AUC为0.925;超声内镜弹性成像评分在1级与2/3级间差异有统计学意义(P=0.001),其AUC为0.838。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To establish a preoperative prediction model for pathological grade of PanNETs based on computed tomography (CT), magnetic resonance imaging (MRI) and endoscopic ultrasonography (EUS).
METHODS: Clinical data of 58 patients with pathologically confirmed PanNETs were included in this retrospectively study and they were divided into grade 1 and grade 2/3. CT, MRI and EUS images were collected within one week before surgery. A clinical predictive model based on the independent clinical risk factors and significant radiological features was established. The area under receiver operating characteristic curve (AUC) was performed to assess the model.
RESULTS: Gender, pancreatic duct dilatation (PDD) and portal enhancement ratio (PER) were the independent predictors for PanNETs grading (P < 0.05). PanNETs grade 1 and grade 2/3 had statistical difference in elastography score (P = 0.001). The combination of gender, PDD and PER had better predictive efficiency than each of these three predictors alone, with a high AUC of 0.925. The elastography score also achieved an AUC of 0.838.
CONCLUSION: We proposed a comprehensive model based on preoperative CT, MRI and EUS to predict grade 1 and grade 2/3 of PanNETs and better informs clinicians on individualized diagnosis and treatment of patients with PanNETs.
引用
- Xie Y, Abaydulla E, Zhang S, et al. Preoperative prediction of pancreatic neuroendocrine tumors grade based on computed tomography, magnetic resonance imaging and endoscopic ultrasonography. Abdom Radiol (NY). 2025. PMID: 40105959. doi:10.1007/s00261-025-04865-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。